Udg Healthcare PLC (LON:UDG) had its target price increased by stock analysts at Peel Hunt from GBX 840 ($11.08) to GBX 860 ($11.35) in a research note issued to investors on Tuesday. The brokerage presently has an “add” rating on the stock. Peel Hunt’s price objective would suggest a potential downside of 6.98% from the company’s current price.
A number of other analysts have also recently issued reports on the company. Jefferies Group LLC boosted their target price on Udg Healthcare PLC from GBX 830 ($10.95) to GBX 855 ($11.28) and gave the stock a “hold” rating in a report on Wednesday, October 4th. N+1 Singer reiterated a “hold” rating and set a GBX 770 ($10.16) target price on shares of Udg Healthcare PLC in a report on Tuesday, August 15th. Numis Securities Ltd reiterated a “hold” rating and set a GBX 765 ($10.10) target price on shares of Udg Healthcare PLC in a report on Monday, August 14th. Liberum Capital cut Udg Healthcare PLC to a “hold” rating and decreased their target price for the stock from GBX 930 ($12.27) to GBX 884 ($11.67) in a report on Monday, August 14th. Finally, Stifel Nicolaus reiterated a “hold” rating and set a GBX 775 ($10.23) target price on shares of Udg Healthcare PLC in a report on Thursday, August 3rd. Seven investment analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average target price of GBX 825.71 ($10.90).
ILLEGAL ACTIVITY NOTICE: “Udg Healthcare PLC (UDG) PT Raised to GBX 860 at Peel Hunt” was published by Community Financial News and is the property of of Community Financial News. If you are viewing this piece of content on another domain, it was illegally copied and reposted in violation of U.S. & international trademark & copyright law. The original version of this piece of content can be accessed at https://www.com-unik.info/2017/11/02/udg-healthcare-plc-udg-pt-raised-to-gbx-860-at-peel-hunt.html.
Udg Healthcare PLC Company Profile
UDG Healthcare plc, formerly United Drug plc, is a healthcare services provider in the Republic of Ireland, the United Kingdom, North America and Continental Europe. The Company operates in three segments. The Ashfield Commercial & Medical Services segment is engaged in the provision of sales, marketing and healthcare communications services to pharmaceutical companies, and it also provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance, regulatory and event management services to over 300 healthcare companies.
What are top analysts saying about Udg Healthcare PLC? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Udg Healthcare PLC and related companies.